FDA-Approved Antiparasitic Drugs in the 21st Century: A Success for Helminthiasis?

FDA-Approved Antiparasitic Drugs in the 21st Century: A Success for Helminthiasis?
Trends Parasitol. 2020 May 06;:
Authors: de Moraes J, Geary TG
Abstract
Diseases caused by helminth infections affect more than a quarter of the population of the world, but the therapeutic arsenal is limited. The approval of moxidectin in 2018 and triclabendazole in 2019 by the FDA marked an important moment in the fight against diseases of poverty, such as helminthiases.
PMID: 32387059 [PubMed - as supplied by publisher]

Source: Trends in Parasitology - May 5, 2020 Category: Parasitology Authors: de Moraes J, Geary TG Tags: Trends Parasitol Source Type: research